Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon

Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon–ribavirin

Published:2008-04 Issue:4 Volume:41 Page:264-269
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Salmerón Javier,Casado Jorge,Rueda Paloma Muñoz de,Lafuente Victor,Diago Moises,Romero-Gómez Manuel,Palacios Ángel,León Josefa,Gila Ana,Quiles Rosa,Rodriguez Luis,Ruiz-Extremera Angeles

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference21 articles.

1. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy;Berg;Hepatology,2003

2. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa2a plus ribavirin;Berg;Gastroenterology,2006

3. Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin;Boo;J Clin Virol,2007

4. Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C;Caballero;J Hepatol,2001

5. Early virologic response with pegylated interferons;Craxì;Digest Liver Dis,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics of Genotypic Mutations of the Hepatitis B Virus Associated With Long-Term Entecavir Treatment Determined With Ultradeep Pyrosequencing;Medicine;2016-01

2. Interferon induction regimen for chronic hepatitis C genotype 4 in Egyptian children;Journal of Pediatric Infectious Diseases;2015-07-28

3. Response factors to pegylated interferon-alfa/ribavirin treatment in chronic hepatitis C patients genotype 1b;Archives of Biological Sciences;2014

4. IL28B polymorphism is not associated with HCV protease diversity in patients co-infected with HIV and HCV treated with pegylated interferon and ribavirin;Journal of Medical Virology;2012-08-15

5. Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin;American Journal of Gastroenterology;2011-07